Search for your favorite author
Steve
Amy
Natalie
Gary
this month featured authors
or click on the right to get a complete list of authors
Continue to the categorySubscribe! Newsletter This week's featured author
One article every two weeks from pharma experts
Editor´s Pick
U.S. judge appoints Ken Feinberg mediator for Bayer Roundup settlement talks
A U.S. judge on Wednesday appointed prominent attorney Kenneth Feinberg as mediator for court-mandated settlement talks in the federal litigation over allegations that Bayer AG's glyphosate-based Roundup weed killer caused cancer.
Novartis CEO plans gene therapy price ‘far lower’ than $4 million to $5 million range
Novartis AG's top executive said on Wednesday it expects to price its gene therapy for spinal muscular atrophy “far lower” than the $4 million to $5 million figure the Swiss drugmaker has said it could be worth.
Novartis has 25 blockbusters in the pipeline: CEO
Novartis has 25 potential blockbuster treatments in development, the company said ahead of a management event in the United States on Thursday.
PG&E wins court approval to set up $105 million wildfire assistance fund
PG&E Corp may set up a $105 million housing fund for victims of 2017 and 2018 wildfires in California, which set records for devastation and were blamed on the utility's equipment, the judge overseeing the bankruptcy of the investor-owned power producer ruled on Wednesday.
Senator Gillibrand wants insurance to pay for fertility treatments
U.S. Democratic presidential hopeful Kirsten Gillibrand on Wednesday proposed requiring insurance companies to cover expensive fertility treatments, part of a "Family Bill of Rights" that would also help with adoption and medical care.
More evidence welding fumes raise lung cancer risk
(Reuters Health) - Workers exposed to welding fumes are more likely to develop lung cancer than those not exposed to the fumes, and a new study suggests this holds true regardless of other risk factors like smoking or exposure to asbestos.
Vaccine doubts spread like disease, must be taken offline: vaccine chief
Doubts about vaccines have spread across social media like a disease and false information that "kills people" should be taken down by the companies running digital platforms, the head of global vaccine alliance Gavi said on Tuesday.
Array BioPharma’s colorectal cancer combo treatment meets main goals
Array BioPharma Inc's cocktail of three therapies helped patients with a type of colorectal cancer live longer than those on standard treatment, according to interim results of a late-stage study on Tuesday.
Merck’s Keytruda fails as monotherapy in breast cancer study
Merck & Co Inc said on Monday its blockbuster cancer drug Keytruda failed to meet the main goal of a late-stage study testing the drug as a standalone treatment in patients with an aggressive type of breast cancer.
Supreme Court gives Merck another shot to avoid Fosamax lawsuits
The U.S. Supreme Court on Monday gave Merck & Co a new opportunity to avoid lawsuits accusing the company of failing to properly warn patients of debilitating thigh-bone fractures from taking its osteoporosis drug Fosamax, throwing out a lower court decision that had revived the litigation.
South Africa’s Aspen sells Australian prescription portfolio to Mylan
Aspen Pharmacare said on Monday that Mylan NV had exercised an option to buy the South African drugmaker's portfolio of prescription and over-the-counter products in Australia for 188 million Australian dollars ($130 million).
U.S. FDA labels J&J surgical staplers’ recall as severest
The U.S. Food and Drug Administration warned of risks of serious injury or death from surgical staplers made by Johnson & Johnson's Ethicon unit, labeling a recent recall of the device as its most serious.
AbbVie halts enrollment after brain cancer trial misses goal, shares fall
AbbVie Inc said on Friday it has halted enrollment of patients in all ongoing studies testing its brain cancer treatment after the drug failed to meet the main goal in a late-stage trial.
Look Who’s On the Move!
Research and Development
Regulatory Affairs
Industry News
